|
1.
|
Dormandy JA and Rutherford RB: Management
of peripheral arterial disease (PAD). TASC Working Group
TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg.
31:S1–S296. 2000.PubMed/NCBI
|
|
2.
|
Murota H, Kotobuki Y, Umegaki N, Tani M
and Katayama I: New aspect of anti-inflammatory action of
lipo-prostaglandin E1 in the management of collagen
diseases-related skin ulcer. Rheumatol Int. 28:1127–1135. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Gao Y, Xu P, Chen L and Li Y:
Prostaglandin E1 encapsulated into lipid nanoparticles improves its
anti-inflammatory effect with low side-effect. Int J Pharm.
387:263–271. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Brass EP, Anthony R, Dormandy J, et al:
Parenteral therapy with lipo-ecraprost, a lipid-based formulation
of a PGE1 analog, does not alter six-month outcomes in patients
with critical leg ischemia. J Vasc Surg. 43:752–759. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Gabriel A, Werba A, Mares P, Grubhofer G,
Hrska F, Griesmacher A, et al: Influence of prostaglandin E1 on
tissue ischemia during surgical repair of the abdominal aorta. J
Cardiothorac Vasc Anesth. 2:201–206. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Willerson JT, Yao SK, McNatt J, Cui K,
Anderson HV, Swensen C, et al: Liposome-bound prostaglandin E1
often prevents cyclic flow variations in stenosed and
endothelium-injured canine coronary arteries. Circulation.
89:1786–1791. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
de Donato G, Gussoni G, de Donato G, Cao
P, Setacci C, Pratesi C, et al: Acute limb ischemia in elderly
patients: can iloprost be useful as an adjuvant to surgery? Results
from the ILAILL study Eur J Vasc Endovasc Surg. 34:194–198.
2007.PubMed/NCBI
|
|
8.
|
Matsagkas M, Kouvelos G, Arnaoutoglou E,
Papa N, Labropoulos N and Tassiopoulos A: Hybrid procedures for
patients with critical limb ischemia and severe common femoral
artery atherosclerosis. Ann Vasc Surg. 25:1063–1069. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Schrijver AM, Moll FL and De Vries JP:
Hybrid procedures for peripheral obstructive disease. J Cardiovasc
Surg (Torino). 51:833–843. 2010.PubMed/NCBI
|
|
10.
|
Conte MS, Geraghty PJ, Bradbury AW,
Hevelone ND, Lipsitz SR, Moneta GL, et al: Suggested objective
performance goals and clinical trial design for evaluating
catheter-based treatment of critical limb ischemia. J Vasc Surg.
50:1462–1473. el–e3. 2009. View Article : Google Scholar
|
|
11.
|
Katzen BT: Clinical diagnosis and
prognosis of acute limb ischemia. Rev Cardiovasc Med. 3(Suppl 2):
S2–S6. 2002.PubMed/NCBI
|
|
12.
|
Aune S and Trippestad A: Operative
mortality and long-term survival of patients operated on for acute
lower limb ischaemia. Eur J Vasc Endovasc Surg. 15:143–146. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Braithwaite BD, Davies B, Birch PA,
Heather BP and Earnshaw JJ: Management of acute leg ischaemia in
the elderly. Br J Surg. 85:217–220. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Nypaver TJ, Whyte BR, Endean ED, Schwarcz
TH and Hyde GL: Nontraumatic lower-extremity acute arterial
ischemia. Am J Surg. 176:147–152. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Pemberton M, Varty K, Nydahl S and Bell
PR: The surgical management of acute limb ischaemia due to native
vessel occlusion. Eur J Vasc Endovasc Surg. 17:72–76. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lipsitz EC, Veith FJ and Wain RA: Digital
fluoroscopy as a valuable adjunct to open vascular operations.
Semin Vasc Surg. 16:280–290. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Bosma HW and Jörning PJ: Intra-operative
arteriography in arterial embolectomy. Eur J Vasc Surg. 4:469–472.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Zaraca F, Stringari C, Ebner JA and Ebner
H: Routine versus selective use of intraoperative angiography
during thromboembolectomy for acute lower limb ischemia: analysis
of outcomes. Ann Vasc Surg. 24:621–627. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Gianetti J, De Caterina M, De Cristofaro
T, Ungaro B, Guercio RD and De Caterina R: Intravenous
prostaglandin E1 reduces soluble vascular cell adhesion molecule-1
in peripheral arterial obstructive disease. Am Heart J.
142:733–739. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Shin M, Song SH, Kim JM, Kim SJ, Joh JW,
Lee SK, et al: Effectiveness of intraportal prostaglandin E1
administration after liver transplantation. Transplant Proc.
44:500–504. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Mitate E, Sasaguri M, Oobu K, Mitsuyasu T,
Tanaka A, Kiyosue T and Nakamura S: Postoperative changes of blood
flow in free microvascular flaps transferred for reconstruction of
oral cavity: effects of intravenous infusion of prostaglandin E1.
Asian J Oral Maxillofacial Surg. 23:113–116. 2011. View Article : Google Scholar
|
|
22.
|
Sim AK, McCraw AP, Cleland ME, Aihara A,
Otomo S, Hosoda K, et al: A preclinical assessment of the effect of
lipo-PGE1 on thrombus formation and thrombus disaggregation. Adv
Drug Deliv Rev. 20:165–170. 1996. View Article : Google Scholar
|
|
23.
|
Marchesi S, Pasqualini L, Lombardini R,
Vaudo G, Lupattelli G, Pirro M, et al: Prostaglandin E1 improves
endothelial function in critical limb ischemia. J Cardiovasc
Pharmacol. 41:249–253. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Luo CF, Wu X, Hu X, Wu GF, Hu CH and Du
ZM: Protective effect of lipid microspheres 1 on myocardial injury
following elective percutaneous coronary intervention in patients
with angina pectoris: a pilot study. J Cardiovasc Med (Hagerstown).
12:790–794. 2011. View Article : Google Scholar
|
|
25.
|
Taylor CJ, McGaw J, Rigby AS, Threlfall D
and Karmel J: Pilot safety study of liposomal prostaglandin (PGE1)
in respiratory exacerbations in cystic fibrosis. J Cyst Fibros.
1:90–93. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Mohler E III and Giri J; ACC; AHA:
Management of peripheral arterial disease patients: comparing the
ACC/AHA and TASC-II guidelines. Curr Med Res Opin. 24:2509–2522.
2008. View Article : Google Scholar : PubMed/NCBI
|
